NYU's Neil Vasan departs as acting chair of FDA's cancer drug advisory panel

Summary

Neil Vasan, acting chair of the FDA's Oncologic Drugs Advisory Committee, has stepped down from his position after participating in 22 ODAC meetings and chairing six.